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Background: Despite advances in medicine, health systems in Latin America are not coping with the challenges of
chronic diseases. Incidence of disease and the economic burdens as a consequence have both increased in recent
years. We have chosen Type 2 diabetes as an example to highlight the challenges posed by chronic diseases, in
terms of the epidemiological transition and the economic burden of the demand for services to treat such
problems.
Discussion: Current health systems are not prepared to respond in a comprehensive manner to all phases of the
natural history of the disease. There are new models of universal coverage, but resources and models of care are
focused on programs aimed at healing/rehabilitation, and very sparsely at detection/prevention.
Summary: In this scenario, chronic problems have alarmingly increased direct costs (medical care) and indirect
costs (temporary disability, permanent disability and premature mortality). If more resources are not assigned to
preventive medicine, these trends, in addition to not meeting the needs of the population, will financially collapse
health systems and the patients’ pockets. This Opinion piece outlines some possible changes that can be
implemented to better prepare the health services in Latin American countries.
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In recent decades, the epidemiological transition that
middle-income countries have been facing creates great
challenges for health systems. Indeed, this phenomenon
of transition has been characterized by a significant
increase in the prevalence of chronic diseases (Type 2
diabetes, renal disease, hypertension, and so on) while
communicable diseases are still present (gastroenteritis,
respiratory infections, vector-borne diseases, and so on).
In this context, health systems have a demand for increas-
ingly diversified services and more financial resources to
meet new demands (for chronic diseases) which compete
widely for the resources allocated to service demands for
communicable diseases.Correspondence: armando.arredondo@insp.mx
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unless otherwise stated.As an example of chronic diseases we can consider
Type 2 diabetes, which has become one of the top dis-
eases contributing to increased morbidity and mortality
in most countries of the world, generating great chal-
lenges for medicine and public health. Indeed, in the lat-
est report from the World Atlas of Diabetes registry for
2010, there are 285 million adults with diabetes [1]. This
number can be expected to continue to increase globally
due to an aging population, growth in population size,
urbanization and a high prevalence of obesity and seden-
tary lifestyles.
As part of the epidemiological transition, the latest
Global Burden of Disease (GBD) recently reported that
by 2010, Type 2 diabetes [2], as a tracer of the global
epidemiological transition, is one of the biggest chal-
lenges facing health systems and societies today.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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The challenges facing existing Latin American health
systems
In most Latin American countries (LACs) (mainly in
Mexico, Argentina, Chile and Brazil), the prevalence of
infectious diseases still presents a burden, and in addition
there has been accelerated growth of chronic diseases,
such as diabetes and hypertension [3,4]. This goes against
the classic model of epidemiological transition with sig-
nificant presence of communicable diseases and non-
communicable diseases. According to the GBD report, the
epidemiological burden of Type 2 diabetes will have the
greatest impact on the health systems and society in LACs
(see Box 1).Box 1 Current trends and challenges to be faced the
coming years by the LACs
 Worldwide, Type 2 diabetes has increased alarmingly in
recent years, and is projected to continue to rise.
 In LACs, health systems continue with the same model of
care that was integrated since the 1940s and have not yet
solved the challenges of treating Type 2 diabetes and its
complications.
 In the context of the epidemiological transition, diabetes
could cause a financial collapse of the health system and
household economies. Currently in LACs, on average 25%
of health expenditure is related to treating diabetes and
related complications.
 If the current trend continues, there will be catastrophic
expenditures for the health system and families - out of
100 pesos spent on diabetes in LACs, 53 are funded by
households and 47 by health institutions.
 Failure to implement key changes in the health system will
present a high cost to society due to premature mortality
and increased disabilities caused by Type 2 diabetes.
 Health systems should move from an approach of treating
diabetes to one of preventing diabetes.With regard to Type 2 diabetes, in economic terms,
the epidemiological transition phenomenon represents a
heavy burden, both in direct costs to the health system
and society and indirect costs attributable to premature
mortality and temporary and permanent disability attrib-
utable to complications of diabetes [5,6]. Indeed, the costs
observed in the group of countries selected for this essay
(Cuba, Venezuela, Colombia, Chile, Argentina, Brazil and
Mexico) [7–9], show increasing trends if current epi-
demiological conditions and current models of care aremaintained. This is especially true for Mexico, Argentina
and Brazil (Figure 1).
On the other hand, in Latin America and the Caribbean,
many people with Type 2 diabetes have limited access to
health care due to the associated high costs and because
public health services are not available to all people; this
means indirect costs may exceed direct health care costs.
This situation generates catastrophic health expenditures,
particularly for the population that is not covered by the
health system.
In terms of the response of the health system in recent
years, health systems in most LACs have undertaken
adjustments, changes or reforms in national health
programs, trying to meet the goal of universal health
insurance. Longer life expectancy and fewer families
impoverished by health problems are some of the re-
sults of the recent adoption of universal health insur-
ance in these countries.
In terms of universal health coverage, we could say
that in the last decade LACs have undergone a great
change. Indeed, we have generated new schemes of uni-
versal health insurance, with significant progress in im-
proving access to health services. The approaches and
results vary from country to country, but the evidence
indicates that one of the shared priorities is to ensure
that quality care reaches the poorest and the population
not covered by the health system [10,11].
Indeed, since 2005, the ‘Argentine Maternal-Child Health
Insurance Program’ has helped introduce historical chan-
ges in the health system in Argentina. More than one mil-
lion pregnant women and children who lacked health
insurance, now have basic health insurance and access to
services for maternal and child health needs [12]. In the
case of Brazil, the Unified Health System funded by taxes,
modernized the Brazilian health system, creating a na-
tional coordinated service that the entire population can
access. They have invested heavily in a primary care
strategy referred to as ‘Family Health’, in which health
professionals, community leaders and heads of families
work together in primary care actions. This strategy has
been the vehicle used to carry out major reforms allowing
families greater access to health care through home visits
and activities to improve health.
In Chile, the ‘Social Health Insurance’ program en-
sures nearly universal health coverage for the country’s
17 million inhabitants. Since 2005, all Chileans have had
access to a basic package that guarantees treatment of
80 health problems such as renal disease, retinopathy,
hypertension, and so on, establishing maximum wait-
ing times for treatment and discretionary spending. In
Colombia, the right to health was established in its
constitution in 1991; 20 years later, access to health ser-
vices has improved considerably thanks to a national
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Figure 1 Epidemiological and economic burden of diabetes in Latin America. Comparing 2010 versus 2025, epidemiological trends of
changes in diabetes in Latin America will have a high impact in economic terms. If no significant changes are made in the current health care
model in these countries, health systems will face a constant and growing increase in the financial resources required to meet the demand for
health services, particularly in countries like Brazil, Argentina and Mexico.
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vices, the subsidized regime has significantly streng-
thened the right to health. In the case of México, the
Popular Health Insurance, covering 50 million people,
promotes access to health care for all those who lack so-
cial security. At the heart of the 2003 health reform, this
coverage package includes more than 200 primary and
secondary treatments for the entire population, includ-
ing health services for both communicable and chronic
degenerative diseases.
Despite advances in coverage under schemes of ‘Uni-
versal Health Insurance’ in all these countries, the epi-
demiological and economic burdens of problems such as
hypertension and Type 2 diabetes are far from resolved,
and prevalence continues to increase incrementally. If
major changes are not implemented into the relevant
health care models, there will be significant challenges
in dealing with the rising costs as shown in Figure 1.
In this context, the problem is that even with more
coverage and access to health care, the model remains
the same as when it originated in the 1940s. Indeed, the
health systems in LACs, are based on a fragmented
model with several institutions providing health care for
people in the formal economy (social security institutes)
versus institutions for population in the informal econ-
omy (ministries of health) [13] . These institutions pro-
vide health services based on a model of care with a
biomedical curative approach [14,15]. The resulting ben-
efits of this model, for chronic problems such as Type 2
diabetes, have not been favorable.
In summary, despite the increased coverage schemes
of universal health insurance, the current characteristicsof the health care models and the expected epidemio-
logical changes for LACs represent catastrophic expen-
ditures for health systems and patients. Moreover, the
high financial burden for governments and societies of
these countries will have to face internal competition in
the allocation of resources to other diseases.
Management of chronic illness requires significant
adjustments to health care practice
As noted in the Background, models of health care in
LACs, from their origins to date, have been structured
and organized primarily to meet the health needs of
patients with communicable diseases. Moreover, these
models have focused their attention on healing actions,
while neglecting early detection and prevention. In the
case of chronic diseases, this is particularly relevant, es-
pecially because it is the ‘silent’ diseases which usually
require the use of health services when the damage has
become difficult to control. Such is the case of Type 2
diabetes and hypertension, where more than half of
cases are diagnosed when complications appear [16].
Recent proposals for risk and health damage prevention
programs with emphasis on early detection are being de-
veloped in several regions of Mexico. These proposals, in
addition to developing various activities for detection and
prevention of risks in diabetes and hypertension, are
mainly aimed at the pre-diabetic or pre-hypertensive
population.
Another important component of these proposals is
that, besides involving traditional health professionals
(physicians and nurses), psychologists, sociologists and
anthropologists are also included as part of the health
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professionals in these health care programs is extremely
important if we consider the cultural and social aspects
that determine the behavior of the user with a chronic
disease, who demands services.
Increased coverage by schemes of ‘Universal Health
Insurance’ has not been sufficient to meet the challenges
of chronic health problems in LACs [17]. In terms of
changes in the health system, a change is needed from
the current system of care which is based on a biomed-
ical, curative, fragmented and inequitable model towards
a socio-medical model that is preventive, comprehensive
and equitable.
The idea of a socio-medical model highlights the role
of social determinants and includes social science pro-
fessionals as part of the health team; it has a holistic ap-
proach and perspective. It includes the need to identify
the impact of social determinants as risk factors, and
also proposes the incorporation of content on social de-
terminants, prevention and detection in the training of
doctors and nurses.
Certainly, the holistic component refers to the design,
development and allocation of resources for activities
aimed at key stages of the natural history of the disease:
detection, prevention, cure and rehabilitation, and to stop
focusing only on healing and rehabilitation. This will
enable more effective detection and control of chronic
illness, with a consequent decrease in the effects of com-
plications and treatment noncompliance. In most LACs,
out of 100 people with diabetes, only 50 are diagnosed,
and of these 50 only 30 continue with treatment and re-
main in control. Such patients have shown evidence of in-
creased knowledge of risk factors and take on preventive
actions to avoid complications once they are diagnosed
with diabetes [18]. Certainly, the proposed approach will
allow for better control of diagnosed cases, involving
patients in self-care and a greater understanding of the
consequences of failing to prevent the complications of
diabetes.
More resources need to be allocated to design, imple-
ment and monitor strategies to move from an approach
of treating, to one of preventing diabetes. In all LACs,
there is little or no intervention for the pre-diabetic po-
pulation. We need to develop and validate new methods
of evaluating the epidemiological and economic burden
in terms of direct costs (health care) and indirect costs
(temporary disability, permanent disability and prema-
ture mortality).
In all LACs, it is necessary to implement new mo-
dels of care and health management that can respond
to the diversification and quantity of health services
that will be needed as a result of the epidemiological
transition, particularly for diabetic and hypertensive
patients.Actions to ensure effective diabetes management in Latin
America
The current model of care must go through a detailed
review in order to propose changes in the physical infra-
structure of facilities and the training of health personnel.
The ways in which this can be done are outlined below:
 Develop infrastructure to expand screening
programs for higher levels of detection, prevention
and control. We also have to implement changes in
the continuing education programs for health
personnel to enable a greater focus on primary care
and preventive medicine (mainly for doctors and
nurses). Social science professionals should be
integrated into health services (medical
anthropologists and medical sociologists) to form
part of the health team to implement new
strategies for detection, prevention and control of
chronic diseases (particularly in countries or areas
with high indigenous populations with Type 2
diabetes).
 Implement a research line on trends in demand and
costs for diabetes and develop new financing
schemes with greater allocation of resources to new
programs targeted to screening and prevention in
the pre-diabetic population.
 Design and implement monitoring systems of
epidemiological surveillance (number of cases) and
economic burden for a periodic measurement that
allows for assessment (preferably annual or
biannual) of the impact of new strategies in
epidemiological trends, as indicators of direct and
indirect costs. This action will help keep track of the
number of identified cases and the likely cost of
those to the health care system, with a view to
refining funding models and ensuring resources are
going where they are needed.
 Design patterns of resource allocation to ensure that
financial requirements are met to address diabetes
based on expected demand. These patterns must
integrate indicators of clinical perspective (inpatient
and outpatient number of cases), epidemiological
perspective (number of cases expected in the short
term), organizational perspective (number of cases
to be taken care of, by level of care) and economic
perspective (average cost case of management by
level of care).
 Implement monitoring systems accompanied by
cost-containment strategies for cost of weight-by-
cost items. For example, knowing that in case
management the cost of medicines is high, it will
be necessary for each institution to review its
agreements with the pharmaceutical industry on the
purchase of medicines for diabetes.
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diabetes, knowledge of the relative weight of the
management of diabetes based on the annual family
income, as well as required knowledge of the cost of
complications to the users, should be made available
through a bulletin sent to patients and their
relatives, and to the community as a whole. Also, a
list of recommendations is needed to promote
greater self-care, monitoring of risk factors and the
benefits of carrying out these measures and, more
importantly, to avoid falling into a catastrophic
situation (to avoid an impact of >30% of the family
income) because of diabetes costs.
 With regard to the indirect costs to society due to
loss of productivity from premature mortality, and
temporary or permanent disability attributable to
diabetes, companies must establish programs in the
workplace for increased detection, prevention,
treatment and control of diabetes and its
complications. This will require developing
agreements with the health system and workers and
will have a positive impact on competitiveness and
productivity.
 The various universal health insurance schemes that
LACs have implemented have already provided the
benefits of increased coverage, in terms of
population size and in health needs not previously
served by the health system, especially in maternal
and child health, some chronic diseases, as well as
some emerging diseases (AIDS, malaria, and so on.).
Even with such benefits, limitations persist in the
current structure of the health systems. Indeed, this
structure has been the same for the past half
century. The health systems of these countries must
be reorganized to be more consistent with the state
of the art of medicine and with the population’s
health needs.
Summary
In the context of ongoing reforms in the health systems
of LACs, and taking into account the state of the art of
medicine, universal coverage for health care will be ef-
fective only if it meets the health needs in all phases of
the natural history of disease: prevention, detection,
treatment and rehabilitation, particularly in the case of
chronic health problems.
Certainly, the challenges posed in this paper are based
on the evidence that universal coverage to address dia-
betes poses great challenges for detection and preven-
tion. Not only does the health system not solve half of
the diabetes cases, but it does little or nothing to detect
the population with pre-diabetes.
We need to emphasize that, although medicine pro-
vides all the elements to solve the problem of diabetes,the health system is limiting its services to the patient
population that requires healing or rehabilitation from
complications.
Indeed, as health systems are organized in the LACs,
focusing only on cure and rehabilitation, the cases that
need detection and prevention of diabetes are not knoc-
king on the door of the health system. We currently
ignore the pre-diabetic population. This is even more
serious if we consider that a large percentage of people
with diabetes request the services of the health system
when they already have some of the major complications
in co-morbidity with diabetes: nephropathy, retinopathy,
neuropathy and cardiovascular disease.
In other words, the absence of a culture of health be-
havior based on a preventive medicine model to meet
the challenges of chronic diseases, such as diabetes, fur-
ther complicates the situation in a health system that
from its inception was designed, structured and orga-
nized to respond basically to communicable diseases and
focus on curing or rehabilitating the sick person.
All of the above, in economic terms has important im-
plications for medicine and health care, for families and
patients with diabetes and for society as a whole. These
implications represent two important economic burdens:
the direct costs of detecting, preventing, treating and re-
habilitating patients with diabetes or pre-diabetes; and in-
direct costs for temporary disability, permanent disability
and premature death from complications of diabetes.
The panorama of challenges facing countries under-
going an epidemiological transition, including Type 2
diabetes and other chronic diseases, is not easy to face
and solve, even with recent health care reforms imple-
mented in LACs. If these schemes do not develop effect-
ive strategies for universal coverage, with changes in the
model of care and more resources allocated to detection
and prevention of chronic illness, the problem will con-
tinue. A transition from a curative model to a more ho-
listic model that emphasizes prevention, detection, and
long-term follow-up is urgently required. In the absence
of these changes, chronic illnesses will continue to be
poorly detected and universal health coverage will not
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